Effects of High-Dose Vitamin D Supplementation on Phase Angle and Physical Function in Patients with Prostate Cancer on ADT

Julia E Inglis, Isabel D Fernandez, Edwin van Wijngaarden, Eva Culakova, Jennifer E Reschke, Amber S Kleckner, Po-Ju Lin, Karen M Mustian, Luke J Peppone, Julia E Inglis, Isabel D Fernandez, Edwin van Wijngaarden, Eva Culakova, Jennifer E Reschke, Amber S Kleckner, Po-Ju Lin, Karen M Mustian, Luke J Peppone

Abstract

Purpose: Androgen deprivation therapy (ADT) is commonly used to treat patients with advanced prostate cancer but is associated with functional decline. Bioelectrical impedance analysis (BIA)-derived phase angle may reflect frailty and functional decline in cancer patients. High-dose vitamin D supplementation may improve phase angle values and physical function.

Methods: We conducted an exploratory analysis from a phase II randomized controlled trial investigating the efficacy of high-dose vitamin D supplementation in prostate cancer patients (age ≥ 60 yrs). Fifty-nine patients were randomized to high-dose vitamin D (600 IU/day plus 50,000 IU/week) or low-dose: RDA for vitamin D (600 IU/day plus placebo weekly) for 24 weeks. Phase angle was measured by BIA. Physical function measures included handgrip strength, 6-minute walk test, Short Performance Physical Battery and leg extension. All testing was completed at baseline, week 12 and week 24.

Results: Phase angle values were wider over the entire study in the high-dose vitamin D arm indicating healthier muscle cells. The low-dose vitamin D arm had phase angle values consistent with frailty cutoffs in older men (<5.7°).

Conclusion: Patients in the high-dose vitamin D arm experienced wider phase angle values over the course of the study which may indicate less frailty. ClinicalTrials.gov ID: NCT02064946.

Conflict of interest statement

Disclosure of Interest

The authors report no conflict of interest.

Conflicts of Interest: The authors have no relevant affiliations or financial involvement with any organization or entity with the subject matter or materials discussed in this manuscript and therefore, have no conflict of interest to declare.

Figures

Figure 1.
Figure 1.
Change in phase angle values from baseline at week 12 and week 24, low-dose and high dose arms. Red line indicates frailty cutoff in older men (5.7°).

Source: PubMed

3
구독하다